<?xml version="1.0" encoding="UTF-8"?>
<p id="Par167">Patients who have had HSE may find it recurs [
 <xref ref-type="bibr" rid="CR69">69</xref>]. Such relapses may happen early, within weeks after the disease, or later, after months or years [
 <xref ref-type="bibr" rid="CR70">70</xref>]. Relapse rates of up to 24% have been reported [
 <xref ref-type="bibr" rid="CR62">62</xref>]. The reactivation of the virus is triggered by the release of corticosteroids under stressful conditions responsible for activating the c-Jun N-terminal kinases pathway. The methylation/phosphorylation switch is then switched on and viral gene expression can proceed [
 <xref ref-type="bibr" rid="CR71">71</xref>]. Patients present with a variety of neurological symptoms, of which abnormal movement is the most common, present in 56% of patients studied by Schleede et al. Other important clinical manifestations are lethargy, seizures, hemiparesis and cranial nerve palsies [
 <xref ref-type="bibr" rid="CR62">62</xref>]. Patients may have a negative HSV PCR during these episodes [
 <xref ref-type="bibr" rid="CR69">69</xref>].
</p>
